Methergine® lowers the risk of hemorrhage-related morbidity1

Demonstrated lower risk of hemorrhage-related morbidity during cesarean delivery compared with carboprost1

Methergine is proven to lower the risk of hemorrhage-related morbidity in patients undergoing cesarean delivery vs carboprost
(risk ratio=1.7)1

* Defined as intraoperative and postoperative red blood cell transfusion or the need for additional surgical interventions, including uterine artery ligation, hypogastric artery ligation, or peripartum hysterectomy for atony.
RR, relative risk.
Previous Next
PPH In The US Is Increasing | Know Postpartum Hemorrhage Risks

Ensure your patients are protected from Hospital to Home

  1. Butwick AJ, Carvalho B, Blumenfeld YJ, El-Sayed, YY, Nelson LM, Bateman BT. Second-line Uterotonics and the risk of hemorrhage-related morbidity.Am J Obstet Gynecol. 2015;212(5):642.e1-642.e7.